Protein kinase D increases maximal Ca2+-activated tension of cardiomyocyte contraction by phosphorylation of cMyBP-C-Ser315.

Standard

Protein kinase D increases maximal Ca2+-activated tension of cardiomyocyte contraction by phosphorylation of cMyBP-C-Ser315. / Dirkx, Ellen; Cazorla, Olivier; Schwenk, Robert W; Lorenzen-Schmidt, Ilka; Sadayappan, Sakthivel; Johan, Van Lint; Carrier, Lucie; Eys, van; Guillaume, J J M; Glatz, Jan F C; Luiken, Joost J F P.

in: AM J PHYSIOL-HEART C, Jahrgang 303, Nr. 3, 3, 2012, S. 323-331.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Dirkx, E, Cazorla, O, Schwenk, RW, Lorenzen-Schmidt, I, Sadayappan, S, Johan, VL, Carrier, L, Eys, V, Guillaume, JJM, Glatz, JFC & Luiken, JJFP 2012, 'Protein kinase D increases maximal Ca2+-activated tension of cardiomyocyte contraction by phosphorylation of cMyBP-C-Ser315.', AM J PHYSIOL-HEART C, Jg. 303, Nr. 3, 3, S. 323-331. <http://www.ncbi.nlm.nih.gov/pubmed/22636676?dopt=Citation>

APA

Dirkx, E., Cazorla, O., Schwenk, R. W., Lorenzen-Schmidt, I., Sadayappan, S., Johan, V. L., Carrier, L., Eys, V., Guillaume, J. J. M., Glatz, J. F. C., & Luiken, J. J. F. P. (2012). Protein kinase D increases maximal Ca2+-activated tension of cardiomyocyte contraction by phosphorylation of cMyBP-C-Ser315. AM J PHYSIOL-HEART C, 303(3), 323-331. [3]. http://www.ncbi.nlm.nih.gov/pubmed/22636676?dopt=Citation

Vancouver

Dirkx E, Cazorla O, Schwenk RW, Lorenzen-Schmidt I, Sadayappan S, Johan VL et al. Protein kinase D increases maximal Ca2+-activated tension of cardiomyocyte contraction by phosphorylation of cMyBP-C-Ser315. AM J PHYSIOL-HEART C. 2012;303(3):323-331. 3.

Bibtex

@article{e6132610587a4060aa28eca2d52463cf,
title = "Protein kinase D increases maximal Ca2+-activated tension of cardiomyocyte contraction by phosphorylation of cMyBP-C-Ser315.",
abstract = "Cardiac myosin-binding protein C (cMyBP-C) is involved in the regulation of cardiac myofilament contraction. Recent evidence showed that protein kinase D (PKD) is one of the kinases that phosphorylate cMyBP-C. However, the mechanism by which PKD-induced cMyBP-C phosphorylation affects cardiac contractile responses is not known. Using immunoprecipitation, we showed that, in contracting cardiomyocytes, PKD binds to cMyBP-C and phosphorylates it at Ser(315). The effect of PKD-mediated phosphorylation of cMyBP-C on cardiac myofilament function was investigated in permeabilized ventricular myocytes, isolated from wild-type (WT) and from cMyBP-C knockout (KO) mice, incubated in the presence of full-length active PKD. In WT myocytes, PKD increased both myofilament Ca(2+) sensitivity (pCa(50)) and maximal Ca(2+)-activated tension of contraction (T(max)). In cMyBP-C KO skinned myocytes, PKD increased pCa(50) but did not alter T(max). This suggests that cMyBP-C is not involved in PKD-mediated sensitization of myofilaments to Ca(2+) but is essential for PKD-induced increase in T(max). Furthermore, the phosphorylation of both PKD-Ser(916) and cMyBP-C-Ser(315) was contraction frequency-dependent, suggesting that PKD-mediated cMyBP-C phosphorylation is operational primarily during periods of increased contractile activity. Thus, during high contraction frequency, PKD facilitates contraction of cardiomyocytes by increasing Ca(2+) sensitivity and by an increased T(max) through phosphorylation of cMyBP-C.",
keywords = "Animals, Male, Mice, Mice, Knockout, Rats, Electric Stimulation, Phosphorylation, Immunoprecipitation, Protein Binding, Rats, Inbred Lew, Adrenergic beta-Antagonists/pharmacology, Carrier Proteins/genetics/*metabolism, *Excitation Contraction Coupling/drug effects, *Myocardial Contraction/drug effects, Myocytes, Cardiac/drug effects/*enzymology, Myofibrils/enzymology, Protein Kinase C/*metabolism, Serine, Animals, Male, Mice, Mice, Knockout, Rats, Electric Stimulation, Phosphorylation, Immunoprecipitation, Protein Binding, Rats, Inbred Lew, Adrenergic beta-Antagonists/pharmacology, Carrier Proteins/genetics/*metabolism, *Excitation Contraction Coupling/drug effects, *Myocardial Contraction/drug effects, Myocytes, Cardiac/drug effects/*enzymology, Myofibrils/enzymology, Protein Kinase C/*metabolism, Serine",
author = "Ellen Dirkx and Olivier Cazorla and Schwenk, {Robert W} and Ilka Lorenzen-Schmidt and Sakthivel Sadayappan and Johan, {Van Lint} and Lucie Carrier and van Eys and Guillaume, {J J M} and Glatz, {Jan F C} and Luiken, {Joost J F P}",
year = "2012",
language = "English",
volume = "303",
pages = "323--331",
journal = "AM J PHYSIOL-HEART C",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "3",

}

RIS

TY - JOUR

T1 - Protein kinase D increases maximal Ca2+-activated tension of cardiomyocyte contraction by phosphorylation of cMyBP-C-Ser315.

AU - Dirkx, Ellen

AU - Cazorla, Olivier

AU - Schwenk, Robert W

AU - Lorenzen-Schmidt, Ilka

AU - Sadayappan, Sakthivel

AU - Johan, Van Lint

AU - Carrier, Lucie

AU - Eys, van

AU - Guillaume, J J M

AU - Glatz, Jan F C

AU - Luiken, Joost J F P

PY - 2012

Y1 - 2012

N2 - Cardiac myosin-binding protein C (cMyBP-C) is involved in the regulation of cardiac myofilament contraction. Recent evidence showed that protein kinase D (PKD) is one of the kinases that phosphorylate cMyBP-C. However, the mechanism by which PKD-induced cMyBP-C phosphorylation affects cardiac contractile responses is not known. Using immunoprecipitation, we showed that, in contracting cardiomyocytes, PKD binds to cMyBP-C and phosphorylates it at Ser(315). The effect of PKD-mediated phosphorylation of cMyBP-C on cardiac myofilament function was investigated in permeabilized ventricular myocytes, isolated from wild-type (WT) and from cMyBP-C knockout (KO) mice, incubated in the presence of full-length active PKD. In WT myocytes, PKD increased both myofilament Ca(2+) sensitivity (pCa(50)) and maximal Ca(2+)-activated tension of contraction (T(max)). In cMyBP-C KO skinned myocytes, PKD increased pCa(50) but did not alter T(max). This suggests that cMyBP-C is not involved in PKD-mediated sensitization of myofilaments to Ca(2+) but is essential for PKD-induced increase in T(max). Furthermore, the phosphorylation of both PKD-Ser(916) and cMyBP-C-Ser(315) was contraction frequency-dependent, suggesting that PKD-mediated cMyBP-C phosphorylation is operational primarily during periods of increased contractile activity. Thus, during high contraction frequency, PKD facilitates contraction of cardiomyocytes by increasing Ca(2+) sensitivity and by an increased T(max) through phosphorylation of cMyBP-C.

AB - Cardiac myosin-binding protein C (cMyBP-C) is involved in the regulation of cardiac myofilament contraction. Recent evidence showed that protein kinase D (PKD) is one of the kinases that phosphorylate cMyBP-C. However, the mechanism by which PKD-induced cMyBP-C phosphorylation affects cardiac contractile responses is not known. Using immunoprecipitation, we showed that, in contracting cardiomyocytes, PKD binds to cMyBP-C and phosphorylates it at Ser(315). The effect of PKD-mediated phosphorylation of cMyBP-C on cardiac myofilament function was investigated in permeabilized ventricular myocytes, isolated from wild-type (WT) and from cMyBP-C knockout (KO) mice, incubated in the presence of full-length active PKD. In WT myocytes, PKD increased both myofilament Ca(2+) sensitivity (pCa(50)) and maximal Ca(2+)-activated tension of contraction (T(max)). In cMyBP-C KO skinned myocytes, PKD increased pCa(50) but did not alter T(max). This suggests that cMyBP-C is not involved in PKD-mediated sensitization of myofilaments to Ca(2+) but is essential for PKD-induced increase in T(max). Furthermore, the phosphorylation of both PKD-Ser(916) and cMyBP-C-Ser(315) was contraction frequency-dependent, suggesting that PKD-mediated cMyBP-C phosphorylation is operational primarily during periods of increased contractile activity. Thus, during high contraction frequency, PKD facilitates contraction of cardiomyocytes by increasing Ca(2+) sensitivity and by an increased T(max) through phosphorylation of cMyBP-C.

KW - Animals

KW - Male

KW - Mice

KW - Mice, Knockout

KW - Rats

KW - Electric Stimulation

KW - Phosphorylation

KW - Immunoprecipitation

KW - Protein Binding

KW - Rats, Inbred Lew

KW - Adrenergic beta-Antagonists/pharmacology

KW - Carrier Proteins/genetics/metabolism

KW - Excitation Contraction Coupling/drug effects

KW - Myocardial Contraction/drug effects

KW - Myocytes, Cardiac/drug effects/enzymology

KW - Myofibrils/enzymology

KW - Protein Kinase C/metabolism

KW - Serine

KW - Animals

KW - Male

KW - Mice

KW - Mice, Knockout

KW - Rats

KW - Electric Stimulation

KW - Phosphorylation

KW - Immunoprecipitation

KW - Protein Binding

KW - Rats, Inbred Lew

KW - Adrenergic beta-Antagonists/pharmacology

KW - Carrier Proteins/genetics/metabolism

KW - Excitation Contraction Coupling/drug effects

KW - Myocardial Contraction/drug effects

KW - Myocytes, Cardiac/drug effects/enzymology

KW - Myofibrils/enzymology

KW - Protein Kinase C/metabolism

KW - Serine

M3 - SCORING: Journal article

VL - 303

SP - 323

EP - 331

JO - AM J PHYSIOL-HEART C

JF - AM J PHYSIOL-HEART C

SN - 0363-6135

IS - 3

M1 - 3

ER -